Indirect traumatic optic neuropathy complicated with periorbital facial bone fracture

被引:23
|
作者
Hsieh, CH
Kuo, YR
Hung, HC
Tsai, HH
Jeng, SF
机构
[1] Chang Gung Univ, Dept Plast & Reconstruct Surg, Chang Gung Mem Hosp, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Coll Dent Med, Kaohsiung, Taiwan
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2004年 / 56卷 / 04期
关键词
traumatic optical neuropathy; facial bone fracture; megadose steroid; facial bone repair; visual acuity;
D O I
10.1097/01.TA.0000071298.97591.60
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study evaluated the outcome for 45 consecutive, nonrandomized patients whose indirect type traumatic optic neuropathy and periorbital facial bone fracture were treated at the Chang Gong Memorial Hospital in Kaohsiung between June of 1996 and June of 2001. There were a total of 48 eye injuries in 45 patients (3 patients sustained bilateral eye injuries). Data related to megadose steroid treatment, timing of open reduction and internal fixation for periorbital facial fractures, and pretreatment and post-treatment of visual acuities were collected from the medical records. Measurements of visual improvement in terms of degree and percentage were calculated after the visual acuities were converted into the log of the minimum angle of resolution units. Visual acuities were significantly improved according to mechanism of injury, gender, or associated periorbital skin laceration wound. However, no light perception for eight patients at initial presentation and gradually deteriorating vision in four injured eyes of three patients were identified as poor prognostic factors. Therefore, repeated visual measurements are recommended to detect any gradually deteriorating vision, which although uncommon, has a poor prognosis. No significantly improved vision was found after treatment with megadose steroids. However, if improvement in vision did occur, treatment with megadose steroids resulted in a much greater visual improvement in terms of degree (p = 0.001) and percentage (p = 0.02). Thus treatment with megadose steroid is recommended. No significant differences were found in the visual improvement between those who received and those who did not receive periorbital open reduction and internal fixation operations, and between those who received early repair within 48 hours and those who received late repair after more than 48 hours. However, it seems medicolegally prudent to delay the procedure because some patients may experience gradually deteriorating vision, which has a poor prognosis, and because postoperative visual loss after facial fracture repair did happen.
引用
收藏
页码:795 / 801
页数:7
相关论文
共 27 条
  • [21] Traumatic optic neuropathy in orbital wall fractures- diagnostic parameters and treatment outcomes: A prospective observational study
    Natarajan, Srivalli
    Baviskar, Padmakar S.
    Gandevivala, Adil
    Gupta, Himika
    Vichare, Shruti N.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2022, 123 (02) : 171 - 176
  • [22] Predictive value of visual evoked potentials, relative afferent pupillary defect, and orbital fractures in patients with traumatic optic neuropathy
    Tabatabaei, Seyed Ali
    Soleimani, Mohammad
    Alizadeh, Mahdi
    Movasat, Morteza
    Mansoori, Mohammad Reza
    Alami, Zakieh
    Foroutan, Alireza
    Joshaghani, Mahmood
    Safari, Saeid
    Goldiz, Arzhang
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 1021 - 1026
  • [23] Computer Aided Facial Bone Fracture Diagnosis (CA-FBFD) System Based on Object Detection Model
    Moon, Gwiseong
    Kim, Seola
    Kim, Woojin
    Kim, Yoon
    Jeong, Yeonjin
    Choi, Hyun-Soo
    IEEE ACCESS, 2022, 10 : 79061 - 79070
  • [24] Comparison between retinal nerve fiber layer and macular thickness measured with OCT detecting progressive axonal loss following traumatic optic neuropathy
    Cunha, Leonardo Provetti
    Ferreira Costa-Cunha, Luciana Virginia
    Santiago Malta, Roberto Freire
    Ribeiro Monteiro, Mario Luiz
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2009, 72 (05) : 622 - 625
  • [25] Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation
    Valerio Carelli
    Nancy J. Newman
    Patrick Yu-Wai-Man
    Valerie Biousse
    Mark L. Moster
    Prem S. Subramanian
    Catherine Vignal-Clermont
    An-Guor Wang
    Sean P. Donahue
    Bart P. Leroy
    Robert C. Sergott
    Thomas Klopstock
    Alfredo A. Sadun
    Gema Rebolleda Fernández
    Bart K. Chwalisz
    Rudrani Banik
    Jean François Girmens
    Chiara La Morgia
    Adam A. DeBusk
    Neringa Jurkute
    Claudia Priglinger
    Rustum Karanjia
    Constant Josse
    Julie Salzmann
    François Montestruc
    Michel Roux
    Magali Taiel
    José-Alain Sahel
    Ophthalmology and Therapy, 2023, 12 : 401 - 429
  • [26] Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison
    Newman, Nancy J.
    Yu-Wai-Man, Patrick
    Carelli, Valerio
    Biousse, Valerie
    Moster, Mark L.
    Vignal-Clermont, Catherine
    Sergott, Robert C.
    Klopstock, Thomas
    Sadun, Alfredo A.
    Girmens, Jean-Francois
    La Morgia, Chiara
    DeBusk, Adam A.
    Jurkute, Neringa
    Priglinger, Claudia
    Karanjia, Rustum
    Josse, Constant
    Salzmann, Julie
    Montestruc, Francois
    Roux, Michel
    Taiel, Magali
    Sahel, Jose-Alain
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [27] Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation
    Carelli, Valerio
    Newman, Nancy J.
    Yu-Wai-Man, Patrick
    Biousse, Valerie
    Moster, Mark L.
    Subramanian, Prem S.
    Vignal-Clermont, Catherine
    Wang, An-Guor
    Donahue, Sean P.
    Leroy, Bart P.
    Sergott, Robert C.
    Klopstock, Thomas
    Sadun, Alfredo A.
    Fernandez, Gema Rebolleda
    Chwalisz, Bart K.
    Banik, Rudrani
    Girmens, Jean Francois
    La Morgia, Chiara
    DeBusk, Adam A.
    Jurkute, Neringa
    Priglinger, Claudia
    Karanjia, Rustum
    Josse, Constant
    Salzmann, Julie
    Montestruc, Francois
    Roux, Michel
    Taiel, Magali
    Sahel, Jose-Alain
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (01) : 401 - 429